Edelman Joseph's Form 4 filing
Aldeyra Therapeutics, Inc. (ALDX) · filed Aug 11, 2022
- Accession no.
- 0001062993-22-017733
- Filed
- Aug 11, 2022, 4:08 PM ET
- Trade date
- Aug 9-10, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $867.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edelman JosephCIK 0001164426 | 10% Owner |
| Perceptive Advisors LLCCIK 0001224962 | 10% Owner |
| Perceptive Life Sciences Master Fund LtdCIK 0001249675 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2022 | Common Stock | PPurchaseAcquired | +100,000 | $7.50 | +$750,000 | 11,335,085 | Indirect | |
| Aug 10, 2022 | Common Stock | PPurchaseAcquired | +15,000 | $7.85 | +$117,750 | 11,350,085 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.